# US 3D Medical Printing Market

> US 3D Medical Printing Market Research Report Information By Component (Equipment (3D Printers, 3D Bioprinters), Metals and Metal Alloys, Biomaterials, Ceramics, Materials (Plastics (Thermoplastics, Photopolymers), Paper, Wax, Other Materials) and Services & Software), By Application (Surgical Instruments (Surgical Fasteners, Scalpels, Retractors), By End User (Hospitals & Surgical Centers, Dental & Orthopedic Clinics, Pharma-Biotech & Medical Device Companies, Academic Institutions & Research Laboratories, and Clinical Research Organizations) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.3%
- **2024:** $ 945 Million
- **2025:** $ 1,041.6 Million
- **2035:** $ 2,513.7 Million
- **Key Players:** Stratasys (US), 3D Systems (US), Materialise (US), Siemens (US), GE Additive (US), Formlabs (US), HP Inc. (US), Medtronic (US), Stryker (US), B. Braun (US)

**Report ID:** MRFR/MED/11131-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-3d-medical-printing-market-12654

---

## Market Summary

## **US 3D Medical Printing Market Overview**

As per MRFR analysis, the US 3D Medical Printing Market Size was estimated at 9.56 (USD Billion) in 2024. The US 3D Medical Printing Market Industry is expected to grow from 11.14 (USD Billion) in 2025 to 44.36 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 16.59% during the forecast period (2025 - 2034). One of the main market drivers of growth in the 3D medical printing market is the major players in the industry's quick technological advancements.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **3D Medical Printing Market Trends**

The increasing incidence of osteoarthritis and related musculoskeletal disorders is one of the main drivers driving the market for US 3D medical printing. Patients with osteoarthritis experience pain, stiffness, and a loss of joint function as a result of the disease, which damages the cartilage in the joints and the tissues around them. Surgeons can access important information that may not be accessible on a 2-dimensional scan by employing 3D printing technology to replicate a patient's joint. Osteoarthritis is more common as people get older. For instance, a survey from the U.S.

National Library of Medicine predicts that by 2040, 78 million (or 26%) of adult Americans who are 18 years of age and older would have a formal diagnosis of arthritis. Therefore, encouraging the adoption of medical gadgets that are 3D printed and facilitating industry growth.

For those who are in need, organ transplantation is an essential and frequently life-saving action. It is now feasible to finish this process without depending on human donors because to developments in medical technology. The number of organ transplants performed worldwide in 2021 was 144.302, as reported by the Global Observatory on Donation and Transplantation. Organ transplant waiting lists included 104,234 men, women, and children as of 2022. Organ transplant recipients in the United States lose up to 17 lives every day as a result of the lack of resources and information surrounding organ donation.

This yearly death toll exceeds 6,000. Furthermore, the lack of organ donors and the high rate of organ failure is restricting the growing need for transplantable organs; nevertheless, medical 3D printing holds promise to address these issues. The prevalence of organ failures has increased due to factors including heavy tobacco usage, sedentary lifestyles, accidents, and chronic diseases, which has further boosted the demand for organ transplantation. Thus, driving the 3D medical printing market revenue.

## **3D Medical Printing Market Segment Insights:**

### **3D Medical Printing Component Insights**

The US 3D Medical Printing market segmentation, based on component includes Equipment (3D Printers, 3D Bioprinters), Metals and Metal Alloys, Biomaterials, Ceramics, Materials (Plastics (Thermoplastics, Photopolymers), Paper, Wax, Other Materials) and Services & Software. The equipment segment dominated the market mostly. Due to its portability and ability to be transported to remote locations, the sophisticated technology utilized in the healthcare industry has expanded the scope of services available. To ensure that the operation proceeds without a hitch and that the intended outcomes are obtained, it is imperative that the healthcare industry provides faultless services.

### **3D Medical Printing Application Insights**

The US 3D Medical Printing market segmentation, based on application includes Surgical Instruments (Surgical Fasteners, Scalpels, Retractors), Surgical Guides (Dental Guides, Craniomaxillofacial Guides, Orthopedic Guides, Spinal Guides), Standard Prosthetics & Implants, Custom Prosthetics & Implants (Orthopedic Implants, Craniomaxillofacial Implants, Dental Prosthetics & Implants,), Tissue-engineered Products (Bone & Cartilage Scaffolds, Ligament & Tendon Scaffolds), Hearing Aids, Wearable Medical Devices, and Other Applications. The wearable medical devices segment dominated the market mostly because of the abundance of patients, the relaxation of rules governing 3D printers, the rise in the use of this technology in hospitals and dentistry offices, and customizations.

During the course of the forecast period, these factors are anticipated to accelerate market growth.

### **3D Medical Printing Technology Insights**

The US 3D Medical Printing market segmentation, based on technology includes Laser Beam Melting (Direct Metal Laser Sintering, Selective Laser Sintering, Selective Laser Melting, LaserCUSING), Droplet Deposition/Extrusion-based Technologies (Fused Deposition Modeling, Multiphase Jet Solidification, Low-temperature Deposition Manufacturing, Microextrusion Bioprinting), Photopolymerization (Digital Light Processing, Stereolithography, Two-photon Polymerization, PolyJet 3D Printing), Electron Beam Melting, Three-dimensional Printing/Adhesion Bonding/Binder Jetting, and Other Technologies. The Droplet Deposition/Extrusion-based Technologies segment dominated the market mostly. The ability of 3D printing technology to withstand chemicals has become one of its main draws for prospective customers.

Due to their ability to tolerate extremely high temperatures, these materials are found in many highly durable items on the market. The market's size has increased significantly due to the growing demand for new technology among consumers, and this trend is anticipated to continue in the coming years.

### **3D Medical Printing End User Insights**

The US 3D Medical Printing market segmentation, based on end user, includes Hospitals & Surgical Centers, Dental & Orthopedic Clinics, Pharma-Biotech & Medical Device Companies, Academic Institutions & Research Laboratories, and Clinical Research Organizations. The hospitals & surgical centers category generated the most income. The market for 3D medical printing is expanding due to a number of factors, such as increased government and private sector investments in 3D printing technology and a rise in university-business partnerships. These elements have created opportunities for 3D printing's expansion in the healthcare industry.

**Figure 1: US 3D Medical Printing Market, by End User, 2024 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **3D Medical Printing Regional Insights**

The US 3D medical printing market area will grow at a significant rate. The market has grown significantly as a result of the government's acceleration of improvements in the healthcare industry. Growing consumer awareness of the options accessible to them has also contributed to the market's sustained significant revenue growth. One of the main drivers of growth for the 3D medical printing market is the enormous volume of surgical procedures performed in this area.

Furthermore, factors like as significant product releases, a high concentration of manufacturers or market players, collaborations and acquisitions among big companies, and an increase in research activity in the US are some of the ones propelling the 3D medical printing market's expansion.

**3D Medical Printing Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the 3D medical printing market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, 3D medical printing industry must offer cost-effective items.

**Key Companies in the 3D medical printing market include**

## **3D Medical Printing Market Segmentation**

### **3D Medical Printing Component Outlook**

### **3D Medical Printing Application Outlook**

**3D Medical Printing Technology Outlook**

### **3D Medical Printing End User Outlook**

## Market Drivers

### Technological Advancements

The US 3D Medical Printing Market is experiencing rapid technological advancements that enhance the capabilities of 3D printing. Innovations in materials, such as biocompatible polymers and metals, are expanding the range of applications in medical devices and implants. For instance, the introduction of multi-material printing allows for the creation of complex structures that mimic natural tissues. Furthermore, advancements in software for design and simulation are streamlining the production process, reducing time and costs. According to recent data, the market is projected to grow at a compound annual growth rate (CAGR) of over 20% through 2026, driven by these technological improvements. This growth indicates a strong demand for more efficient and effective medical solutions, positioning the US as a leader in the global 3D medical printing landscape.

### Regulatory Support and Frameworks

The regulatory environment plays a significant role in shaping the US 3D Medical Printing Market. The Food and Drug Administration (FDA) has established guidelines that facilitate the approval process for 3D printed medical devices, ensuring safety and efficacy. This regulatory support encourages innovation and investment in the sector, as companies can navigate the approval process more efficiently. Moreover, the FDA's initiatives to promote the use of additive manufacturing in healthcare signal a commitment to advancing this technology. As a result, the market is likely to see an influx of new products and applications, contributing to its expansion. The establishment of clear regulatory frameworks is essential for fostering trust among healthcare providers and patients alike.

### Collaborative Research and Development

Collaborative research and development initiatives are emerging as a vital driver in the US 3D Medical Printing Market. Partnerships between academic institutions, healthcare providers, and industry players are fostering innovation and accelerating the development of new applications. These collaborations often focus on addressing specific medical challenges, such as creating bioprinted tissues for regenerative medicine or developing advanced surgical models for training purposes. Data indicates that such partnerships are likely to increase, with funding for research in 3D printing technologies projected to rise significantly in the coming years. This collaborative approach not only enhances the technological capabilities of 3D printing but also ensures that the solutions developed are aligned with the needs of the healthcare sector, thereby driving market growth.

### Rising Demand for Customized Solutions

Customization is a pivotal driver in the US 3D Medical Printing Market, as healthcare providers increasingly seek tailored solutions for patients. The ability to produce patient-specific implants and prosthetics enhances treatment outcomes and patient satisfaction. For example, 3D printing enables the creation of orthopedic implants that fit the unique anatomy of individual patients, reducing the risk of complications. Market data suggests that the demand for customized medical devices is expected to rise significantly, with a projected market value reaching several billion dollars by 2026. This trend reflects a broader shift towards personalized medicine, where treatments are designed to meet the specific needs of each patient, thereby driving growth in the 3D medical printing sector.

### Cost Efficiency and Resource Optimization

Cost efficiency is a crucial factor propelling the US 3D Medical Printing Market. Traditional manufacturing methods for medical devices often involve high material waste and lengthy production times. In contrast, 3D printing minimizes waste by using only the necessary amount of material, which can lead to substantial cost savings. Additionally, the ability to produce complex geometries in a single print reduces the need for multiple components, further streamlining production. Recent analyses indicate that healthcare facilities adopting 3D printing technologies can reduce costs by up to 30% in certain applications. This financial advantage is particularly appealing to hospitals and clinics facing budget constraints, thereby fostering the growth of the 3D medical printing market in the US.

## Future Outlook

The US 3D Medical Printing Market is projected to grow at a 9.3% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for personalized medicine, and cost-effective production methods.

**New opportunities:**

- Development of bioprinted organ models for preclinical testing. Expansion of on-demand surgical instrument production services. Integration of AI-driven design software for customized implants.

By 2035, the market is expected to be robust, driven by innovation and diverse applications.

## Segment Insights

### By Application: Prosthetics (Largest) vs. Bioprinting (Fastest-Growing)

In the US 3D Medical Printing Market, the application segment is comprised of several pivotal areas including Surgical Planning, Prosthetics, Bioprinting, Medical Devices, and Anatomical Models. Currently, Prosthetics holds a prominent share, dominating the market with its widespread usage in both hospitals and orthopedic applications. Following this, Anatomical Models are gaining traction, thanks to their innovative use in pre-surgical planning and training, while Bioprinting and Medical Devices are emerging as strong contenders in specific niches. Surgical Planning remains integral, reflecting the robust demand for accurate preoperative evaluations.

Prosthetics (Dominant) vs. Bioprinting (Emerging)

Prosthetics has established itself as the dominant application in the US 3D Medical Printing Market, characterized by personalized, adaptive solutions that align closely with patient needs. Companies are increasingly focusing on creating custom prosthetics that enhance patient mobility and quality of life. On the other hand, Bioprinting, though currently less established, is rapidly emerging as a revolutionary field. With advancements in 3D printing technology and materials, there is significant interest in using bioprinted tissues for transplantation and regenerative medicine, driving research and investment in this area. As both sectors evolve, the integration of new technologies promises to enhance the capabilities and applications within medical printing.

### By Technology: Fused Deposition Modeling (Largest) vs. Stereolithography (Fastest-Growing)

The US 3D Medical Printing Market showcases a dynamic distribution of technological segments, with Fused Deposition Modeling (FDM) commanding the largest market share. This method has gained traction due to its cost-effectiveness and ease of use, making it a preferred choice for many healthcare applications. Stereolithography (SLA), while smaller in terms of market share compared to FDM, is rapidly gaining attention, as it offers high precision and speed, which are crucial for producing complex medical models and prototypes.
Recent trends indicate significant growth in the use of advanced printing technologies like SLA. The demand for customized medical solutions and rapid prototyping is driving this trend. Furthermore, innovations in material science and increasing regulatory approvals are propelling the adoption of SLA, positioning it as the fastest-growing segment in the market. Key players are investing heavily in R&D to enhance the capabilities of these technologies, further fueling growth in the market.

Technology: Fused Deposition Modeling (Dominant) vs. Stereolithography (Emerging)

Fused Deposition Modeling (FDM) stands out as the dominant technology within the US 3D Medical Printing Market due to its affordability and simplicity. It utilizes thermoplastic materials to create objects layer by layer, making it accessible for smaller medical facilities and custom applications. Its versatility caters to various medical applications, including the production of anatomical models and surgical aids. On the other hand, Stereolithography (SLA) is emerging rapidly, characterized by high-resolution prints and smooth finishes. It employs a UV light source to solidify liquid resin, enabling the production of intricate designs that are often required in dental and orthopedic applications. As demand for precision in medical modeling rises, SLA's position in the market is strengthening, making it a vital technology for the future.

### By Material: Plastics (Largest) vs. Biomaterials (Fastest-Growing)

In the US 3D Medical Printing Market, the material segment shows a diverse distribution of share among plastics, metals, ceramics, biomaterials, and composites. Plastics dominate this segment due to their versatility, affordability, and ease of processing, capturing the largest proportion. Metals and ceramics also hold significant shares, appealing to high-performance applications, while biomaterials and composites are increasingly making their mark, driven by advancements in material science.

Plastics (Dominant) vs. Biomaterials (Emerging)

Plastics are the dominant material in the US 3D Medical Printing Market, widely used for applications ranging from prosthetics to surgical tools due to their lightweight and customizable nature. Furthermore, they offer a vast array of properties that can be tailored for specific functions, making them applicable in various medical fields. In contrast, biomaterials represent an emerging segment, rapidly gaining traction due to innovative developments that cater specifically to biocompatibility and tissue engineering. Their unique ability to integrate with biological systems positions them as a promising choice for advancing personalized medicine and regenerative therapies, highlighting a dynamic shift in material preferences within the healthcare sector.

### By End Use: Hospitals (Largest) vs. Medical Device Companies (Fastest-Growing)

In the US 3D Medical Printing Market, hospitals hold the largest market share, reflecting their increased adoption of innovative technologies for patient-specific treatments and surgical planning. Hospitals utilize 3D printing for creating personalized prosthetics, anatomical models, and surgical instruments, thereby optimizing clinical outcomes and enhancing operational efficiency.
Research institutions and academic institutions follow, showcasing a growing interest in leveraging 3D printing for academic research and training purposes. Medical device companies also play a significant role, with a notable market presence as they focus on developing advanced, customized medical products using 3D printing technologies, thus serving a diverse range of surgical needs.

Hospitals (Dominant) vs. Research Institutions (Emerging)

Hospitals are the dominant players in the US 3D Medical Printing Market, primarily due to their critical need for personalized medical solutions and the efficiency that 3D technologies provide in surgical applications. They often collaborate with technology companies to integrate advanced printing techniques into their operations, leading to improved patient outcomes and higher satisfaction rates. On the other hand, research institutions are emerging as significant contributors to this market. They are utilizing 3D printing for prototyping and research purposes, thus driving innovations in medical devices and therapeutic strategies. The focus on cutting-edge research and the potential for developing novel medical applications positions them as a vital segment in the evolving landscape of medical 3D printing.

## Regional Market Share Analysis

### North America : Innovation and Leadership Hub

The North American 3D medical printing market is the largest globally, accounting for approximately 45% of the total market share. Key growth drivers include advancements in technology, increasing demand for personalized medicine, and supportive regulatory frameworks. The region benefits from a robust healthcare infrastructure and significant investments in research and development, which are crucial for market expansion. The United States leads the market, with major players like Stratasys, 3D Systems, and GE Additive driving innovation. The competitive landscape is characterized by a focus on technological advancements and strategic partnerships. The presence of leading healthcare institutions further enhances the market's growth potential, making North America a pivotal region in the 3D medical printing landscape.

### Europe : Emerging Market with Potential

Europe is the second-largest market for 3D medical printing, holding around 30% of the global market share. The region is witnessing significant growth due to increasing investments in healthcare technology, rising demand for customized medical solutions, and supportive government initiatives. Regulatory bodies are actively promoting the adoption of 3D printing technologies, which is expected to further boost market growth in the coming years. Leading countries in Europe include Germany, the UK, and France, where key players like Materialise and Siemens are making substantial contributions. The competitive landscape is evolving, with a focus on innovation and collaboration among industry stakeholders. The presence of advanced research institutions and a strong healthcare system positions Europe as a promising market for 3D medical printing.

### Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region is emerging as a significant player in the 3D medical printing market, accounting for approximately 20% of the global share. Key growth drivers include increasing healthcare expenditure, a growing population, and rising awareness of advanced medical technologies. Countries like China and Japan are leading the charge, supported by favorable government policies and investments in healthcare infrastructure. China is at the forefront, with numerous startups and established companies like HP Inc. and Formlabs entering the market. The competitive landscape is characterized by rapid technological advancements and collaborations between healthcare providers and technology firms. As the region continues to develop, the demand for 3D medical printing solutions is expected to rise significantly, enhancing patient care and treatment options.

### Middle East and Africa : Emerging Opportunities Ahead

The Middle East and Africa region is gradually recognizing the potential of 3D medical printing, currently holding about 5% of the global market share. Growth is driven by increasing healthcare investments, a rising prevalence of chronic diseases, and a focus on improving healthcare delivery systems. Governments are beginning to support the adoption of innovative technologies, which is expected to catalyze market growth in the near future. Countries like South Africa and the UAE are leading the way, with initiatives aimed at enhancing healthcare capabilities through technology. The competitive landscape is still developing, with a mix of local and international players entering the market. As awareness of 3D printing benefits grows, the region is poised for significant advancements in medical applications, paving the way for improved patient outcomes.

## Competitive Benchmarking

The 3D Medical Printing Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for personalized medical solutions. Key players such as Stratasys (US), 3D Systems (US), and Materialise (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Stratasys (US) focuses on innovation through the development of advanced materials and software solutions, while 3D Systems (US) emphasizes partnerships with healthcare providers to expand its application range. Materialise (US) leverages its expertise in software and data management to streamline the integration of 3D printing into clinical workflows, collectively shaping a competitive environment that prioritizes technological integration and customer-centric solutions.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure fosters an environment where innovation and operational excellence are critical for success, as companies strive to differentiate themselves in a crowded marketplace.
In December 2025, Stratasys (US) announced a strategic partnership with a leading hospital network to develop customized surgical guides, enhancing precision in complex procedures. This collaboration underscores Stratasys's commitment to integrating 3D printing into surgical practices, potentially revolutionizing patient outcomes and solidifying its position as a leader in the sector. The partnership not only expands Stratasys's market reach but also aligns with the growing trend of personalized medicine.
In November 2025, 3D Systems (US) launched a new line of biocompatible materials specifically designed for dental applications, aiming to capture a larger share of the dental 3D printing market. This strategic move reflects 3D Systems's focus on niche markets and its intent to leverage its technological capabilities to meet specific industry needs. By addressing the unique requirements of dental professionals, the company positions itself as a key player in a rapidly evolving segment.
In October 2025, Materialise (US) unveiled a new software platform that integrates artificial intelligence to optimize the design process for 3D printed medical devices. This innovation not only enhances the efficiency of the design phase but also aligns with the broader trend of digital transformation within the healthcare sector. By incorporating AI, Materialise (US) demonstrates its commitment to staying at the forefront of technological advancements, potentially setting new standards for the industry.
As of January 2026, current competitive trends in the 3D Medical Printing Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding their capabilities. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these elements will be better positioned to thrive in an increasingly complex and competitive landscape.

## Report Scope

| MARKET SIZE 2024 | 945.0 (USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1041.6 (USD Million) |
| MARKET SIZE 2035 | 2513.7 (USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.3% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Stratasys (US), 3D Systems (US), Materialise (US), Siemens (US), GE Additive (US), Formlabs (US), HP Inc. (US), Medtronic (US), Stryker (US), B. Braun (US) |
| Segments Covered | Application, Technology, Material, End Use |
| Key Market Opportunities | Advancements in bioprinting technologies enhance personalized medicine in the US 3D Medical Printing Market. |
| Key Market Dynamics | Technological advancements drive innovation in the US 3D Medical Printing Market, enhancing customization and efficiency. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the projected market valuation of the US 3D Medical Printing Market by 2035?**
A: The projected market valuation for the US 3D Medical Printing Market by 2035 is 2513.7 USD Million.

**Q: What was the market valuation of the US 3D Medical Printing Market in 2024?**
A: The overall market valuation of the US 3D Medical Printing Market was 945.0 USD Million in 2024.

**Q: What is the expected CAGR for the US 3D Medical Printing Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US 3D Medical Printing Market during the forecast period 2025 - 2035 is 9.3%.

**Q: Which application segment is projected to have the highest valuation in the US 3D Medical Printing Market?**
A: The Medical Devices application segment is projected to have the highest valuation, ranging from 300.0 to 800.0 USD Million.

**Q: What are the key technologies utilized in the US 3D Medical Printing Market?**
A: Key technologies include Fused Deposition Modeling, Stereolithography, and Selective Laser Sintering, with valuations ranging from 150.0 to 650.0 USD Million.

**Q: Which materials are predominantly used in the US 3D Medical Printing Market?**
A: Predominantly used materials include Plastics, Metals, and Biomaterials, with Biomaterials expected to reach valuations between 300.0 and 800.0 USD Million.

**Q: What is the expected growth trend for the Prosthetics segment in the US 3D Medical Printing Market?**
A: The Prosthetics segment is expected to grow significantly, with a projected valuation between 200.0 and 600.0 USD Million.

**Q: Who are the leading companies in the US 3D Medical Printing Market?**
A: Leading companies in the market include Stratasys, 3D Systems, and Medtronic, among others.

**Q: What end-use sectors are driving the US 3D Medical Printing Market?**
A: Key end-use sectors include Hospitals and Medical Device Companies, with Hospitals projected to reach valuations between 300.0 and 800.0 USD Million.

**Q: How does the Anatomical Models segment compare to other application segments in terms of valuation?**
A: The Anatomical Models segment is projected to have a valuation between 195.0 and 413.7 USD Million, indicating a moderate position compared to other segments.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-3d-medical-printing-market-12654*